Newer mechanical devices in the management of acute heart failure

Heart Failure Reviews

Volumn 12, Issue 2, 2007, Pages 167-172

  Mather, Paul J ^a,c   Konstam, Marvin A ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute heart failure; Assist devices; Ultrafiltration

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; LOOP DIURETIC AGENT; VASODILATOR AGENT;

ACUTE HEART FAILURE; ADD ON THERAPY; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EQUIPMENT DESIGN; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART ASSIST DEVICE; HEART OUTPUT; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MORTALITY; MYOPATHY; PREVALENCE; ULTRAFILTRATION; UNITED STATES; VALVULAR HEART DISEASE; VIRUS INFECTION;

ACUTE DISEASE; CLINICAL TRIALS; EQUIPMENT DESIGN; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS;

EID: 34250306668     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-007-9018-1     Document Type: Article

References (17)

1. American Heart Association (2004) Heart disease and stroke statistics: 2004 update. American Heart Association, Dallas, TX
2. Berry C, Murdoch DR, McMurray JJ (2001) Economics of chronic heart failure. Eur J Heart Fail 3:283-291
3. Aronow WS, Ahn C, Kronzon I, Koenigsberg M (1991) Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 67:295-299
4. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303-310
5. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. carvedilol heart failure study group. N Engl J Med 334:1349-1355
6. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658
7. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
8. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, Van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Flemming T (2004) Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109:1594-1602
9. Mancini D, Burkhoff D (2005) Mechanical device-based methods of managing and treating heart failure. Circulation 112:438-448
10. Costanzo MR (2006) Ultrafiltration versus IV diuretics for patients hospitalized for acute decompensated congestive heart failure: A prospective randomized clinical trial: UNLOAD. Presented at the American College of Cardiology annual scientific session, March 2006
11. Haithcock BE, Morita H, Fanous NH, Suzuki G, Sabbah HN (2004) Hemodynamic unloading of the failing left ventricle using an arterial-to-arterial extracorporeal flow circuit. Ann Thorac Surg 77:158-163
12. Konstam MA, Czerska B, Bohm M, Oren RM, Sadowski J, Khanal S, Abraham WT, Wasler A, Dahm JB, Gavazzi A, Gradinac S, Legrand V, Mohacsi P, Poelzl G, Radovancevic B, Van Bakel AM, Zile MR, Cabua B, Bartus K, Jansen P (2005) Continuous aortic flow augmentation: Hemodynamic and renal responses to a novel percutaneous intervention in patients with decompensated heart failure. Circulation 112:3107-3114
13. Gharib M, Beizaie M (2003) Correlation between negative near-wall shear stress in human aorta and various stages of congestive heart failure. Ann Biomed Eng 3:678-685
14. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104:2917-2922
15. LaRocca GM, Shimbo D, Rodriguez CJ, Stewart A, Naka Y, Weinberger J, Homma S, Pizzarello R (2006) The impella recover LP 5.0 left ventricular assist device: A bridge to coronary artery bypass grafting and cardiac transplantation. J Am Soc Echocardiogr Apr;19(4):468.e5-7
16. Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ (2006) Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol, Apr 1;97(7):990-992, Epub 2006 Feb 13
17. Registry. ABVW (1999) Courtesy of Abiomed Inc